<DOC>
	<DOCNO>NCT01948570</DOCNO>
	<brief_summary>Primary end point study clinical non-invasive instrumental evaluation activity P-3075 cream subject acne : 20 subject mild/moderate grade 20 subject moderately severe/severe grade , accord Cunliffe ' classification . Secondary end-points cosmetic acceptability efficacy evaluation volunteer local tolerability assess investigator subject .</brief_summary>
	<brief_title>Clinical Study Evaluation P-3075 Cream Acne Treatment</brief_title>
	<detailed_description>This open control clinical trial . The product apply period 4 week 3 visit perform : baseline visit ( T0 ) , intermediate visit 2 week ( T2 ) final visit 4 week-treatment ( T4 ) . The subject enrol divide 2 group accord acne grade ( 20 subject mild/moderate grade 20 subject moderately severe/severe ) , concomitant therapy allow volunteer acne moderately severe/severe . Each volunteer , fulfil inclusion criterion , perform cosmetic treatment study product face , 4 week . A fixed quantity medical device apply face twice day , morning evening ( always hour ) , mild massage accord instruction receive investigator baseline visit ( T0 ) . Group 2 continue also standardise treatment topical systemic retinoids , benzoyl peroxide , clindamycin AHA end study .</detailed_description>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>gender ; age &gt; 16 year old ; acne mild/moderate grade , therapy ( GROUP 1 ) ; acne moderately severe/severe grade , therapy topical systemic retinoids , benzoyl peroxide , clindamycin AHA ( GROUP 2 ) ; accept follow instruction receive investigator ; available return study centre protocol visit ; accept change normal life habit regard : food , physical activity , face cleansing ; accept receive drug/cosmetic treatment able interfere study result ; accept sign inform consent form ( 18 year signature parent require ) . Pregnancy ( female subject ) subject belong Group 2 , control pregnancy test could require T2 T4 case assumption antiacne drug potential teratogenic effect ; subject must confirm use adequate contraceptive precaution order avoid pregnancy ; lactation ( female subject ) ; subject whose insufficient adhesion study protocol expect ; subject change antiacne therapy 2 month prior study inclusion ; concomitant participation study last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>acne , comedo , oily skin</keyword>
</DOC>